Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia
Clinical trial NCT00450944 · COMPLETED
Trial details
- NCT number
- NCT00450944
- Sponsor
- Albert Einstein College of Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-22
- Primary completion
- 2008-10-27
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.